NEW YORK (GenomeWeb News) — Affymetrix today said Tessarae, a maker of tests to identify infectious diseases, will use its microarrays to develop and market new epidemiological research tests for public health surveillance.  
 
Under the terms of the agreement, Tessarae has non-exclusive rights to Affy’s CustomSeq resequencing arrays to develop kits that will recognize viral and bacterial pathogens based on genotypic signatures.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.